Register Login

PROTAGONIST THERAPEUTICS, INC (PTGX)

Director PATEL DINESH V PH D 🟡 adjusted position in 104.7K shares (2 derivative) of Protagonist Therapeutics, Inc (PTGX) at $101.00 ($6.5M) Transaction Date: Mar 23, 2026 | Filing ID: 034736

Full text
Register to leave comments
  • News bot March 25, 2026, 11:23 p.m.

    🔍 PATEL DINESH V PH D (Director)

    Company: Protagonist Therapeutics, Inc (PTGX)

    Report Date: 2026-03-23

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 54,700
    • Total shares sold: 159,400

    Detailed Transactions and Holdings:

    • Sold 50,000 shares of Common Stock (Direct)
      Date: 2026-03-23 | Code: G | equity_swap_involved: 0 | shares_owned_after: 524,938.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 59 shares of Common Stock at $8.58 per share (Direct)
      Date: 2026-03-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 524,997.00 | transaction_form_type: 4
    • Sold 59 shares of Common Stock at $101.0 per share (Direct)
      Date: 2026-03-24 | Code: S | equity_swap_involved: 0 | shares_owned_after: 524,938.00 | transaction_form_type: 4
    • Acquired 54,641 shares of Common Stock at $8.58 per share (Direct)
      Date: 2026-03-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 579,579.00 | transaction_form_type: 4
    • Sold 54,641 shares of Common Stock at $101.0 per share (Direct)
      Date: 2026-03-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 524,938.00 | transaction_form_type: 4
    • Sold 59 shares of Stock Option (right to buy) at $8.58 per share (Derivative)
      Date: 2026-03-24 | Code: M | Expires: 2028-08-14 | equity_swap_involved: 0 | shares_owned_after: 54,641.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 54,641 shares of Stock Option (right to buy) at $8.58 per share (Derivative)
      Date: 2026-03-25 | Code: M | Expires: 2028-08-14 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: This transaction involves a bona fide gift of securities from the Reporting Person to relatives.
    • F2: Includes an aggregate of 433 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2026.
    • F3: These stock options are fully vested.

Search

News categories